Idorsia Ltd/€IDIA

1D1W1MYTD1Y5YMAX

About Idorsia Ltd

Idorsia Ltd is a biopharmaceutical company headquartered in Allschwil, Switzerland. The company focuses on the discovery, development, and commercialization of innovative medicines. Idorsia’s pipeline includes treatments for a variety of conditions, with a particular emphasis on central nervous system disorders, cardiovascular diseases, and rare diseases. Notably, it was founded in June 2017 as a spinoff from Actelion, following its acquisition by Johnson & Johnson. Idorsia leverages its deep scientific expertise to progress its drug candidates from early-stage research through clinical development, aiming to address significant unmet medical needs. Sources: - Company Website - Publicly available financial and corporate reports
Ticker
€IDIA
Sector
Health
Primary listing
XGAT
Employees
456
Headquarters
Allschwil, Switzerland
Website
www.idorsia.com

Idorsia Ltd Metrics

BasicAdvanced
€1.6B
-
-€1.39
1.66
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.